本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Aligos Therapeutics, Inc.

5.29
-0.0100-0.19%
成交量:2.93万
成交额:15.67万
市值:3,234.47万
市盈率:-0.25
高:5.52
开:5.24
低:5.17
收:5.30
数据加载中...
2022/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/04

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/04

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/31

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/01/06

重要事件披露

8-K - Current report
2021/11/18

持股变动声明

3 - Initial statement of beneficial ownership of securities
2021/11/18

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/17

SEC问询函

CORRESP [Cover] - Correspondence
2021/06/28

SEC问询函

CORRESP [Cover] - Correspondence
2021/06/28

SEC问询函

CORRESP [Cover] - Correspondence
2021/06/28

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2021/06/24

重要事件披露

8-K - Current report
2021/06/24

重要事件披露

8-K/A [Amend] - Current report
2021/06/21

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/06/21

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/05/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/10

重要事件披露

8-K - Current report